Skip to content

15% off your first order

Body Composition

Total Shred

Aggressive fat loss with metabolic + endurance support.

  • Lose fat
  • Energy & endurance

Why these are studied together

Tirzepatide and MOTS-c are examined together because they are studied at different levels of metabolic regulation. Tirzepatide is a dual GIP and GLP-1 receptor agonist evaluated in multiple randomized phase 3 trials for weight reduction, appetite, energy intake, and fat mass. MOTS-c is a mitochondrial-encoded peptide studied as a signal between the mitochondria and the nucleus, with research focused on AMPK-associated pathways governing cellular energy management and metabolic homeostasis. The pairing therefore links incretin-driven appetite and glucose signaling with cellular energy regulation. The evidence bases differ considerably: MOTS-c research remains largely preclinical, and human safety data for MOTS-c are limited.

In this stack

All components in stock

$238.00components, bought separately

The builder puts together a stack for this goal, with supplies, and every order ships with a protocol guide for the compounds in it.

Build this stack

Products described on this site are provided for research purposes. Nothing here is a medical claim, and no product is intended to diagnose, treat, cure, or prevent any disease. See our methodology for how this content is sourced and reviewed.